Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Celebrating a major milestone for one of Europe’s biggest type 1 diabetes research cooperations: The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) has successfully screened 100,000 newborns across Europe (including over 7500 newborns in the Thames Valley) for an increased genetic risk of developing type 1 diabetes.

Celebrating a major milestone! Our researchers contribute to the international success of the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD). 100k babies across Europe (inc 7500 newborns in Thames Valley) have now been successfully screened for an increased risk of developing type 1 diabetes.
Load More

Latest news

New Study Reveals AI's Potential in Detecting Heart Defects Before Birth

A recent study with insight from Prof. Aris Papageorghiou, published in The Lancet, highlights how artificial intelligence (AI) could help detect congenital heart defects (CHDs) in unborn babies, with research conducted by one of our research teams and the Institute of Biomedical Engineering.

Team presents Headline Data at the World Congress on Endometriosis in Sydney

Dr Tatjana Gibbons, an investigator on the ongoing DETECT study, presented results at the World Congress on Endometriosis 2025. The study aims to determine the feasibility of detecting endometriosis using 99mTc-maraciclatide and single-photon emission computed tomography.

CRG part of pregnancy trial to prevent anaemia

A new research trial, known as the PANDA study, has been launched to explore whether iron supplementation during pregnancy can reduce the risk of stillbirth.

New Research Unveils Shared Genetic Link Between Endometriosis and Immune Conditions

Research published in the journal Human Reproduction reveals that women with endometriosis are at a significantly higher risk for developing a range of autoimmune, autoinflammatory, and mixed-pattern diseases. This new study, of unprecedented scale, examines not only clinical associations, but also for the first time the biological basis for these comorbidities - through genetics. It identifies osteoarthritis, rheumatoid arthritis, multiple sclerosis, coeliac disease, and psoriasis among the comorbid conditions significantly linked to endometriosis.

Upcoming OxTalks

Our Research Groups